Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg

NCT01885520 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2016-03-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the food effect on the pharmacokinetics of eperisone HCl SR tablet

Conditions

  • Low Back Pain

Interventions

DIETARY_SUPPLEMENT

fasting condition

eperisone SR tablet 75mg administrated under fasting

DIETARY_SUPPLEMENT

fed condition

eperisone SR tablet 75mg administrated fed condition

Sponsors & Collaborators

  • NVP Healthcare

    lead INDUSTRY

Principal Investigators

  • Yoon Yo Ran, M.D., Ph.D. · Kyungpook National University Hospital

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • South Korea

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885520 on ClinicalTrials.gov